AbbVie Inc. (ABBV) Return on equity 2016–2024
AbbVie Inc. (ABBV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
128.7%FY2024 · since FY2016: 128.4% → 128.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 128.7% | +81.7 pp |
| FY2023 | 46.9% | -21.7 pp |
| FY2022 | 68.6% | -6.3 pp |
| FY2021 | 74.9% | +39.6 pp |
| FY2020 | 35.3% | — |
| FY2017 | 104.2% | -24.2 pp |
| FY2016 | 128.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice